SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 132 filers reported holding SERES THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,236 | -51.3% | 2,620 | -1.9% | 0.00% | – |
| Q2 2023 | $12,794 | +426366.7% | 2,671 | +352.7% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 590 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 590 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +150.0% | 590 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 590 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -91.8% | 590 | -90.0% | 0.00% | – |
| Q4 2021 | $49,000 | +1125.0% | 5,890 | +898.3% | 0.00% | – |
| Q3 2021 | $4,000 | -95.7% | 590 | -84.8% | 0.00% | -100.0% |
| Q2 2021 | $93,000 | +675.0% | 3,890 | +559.3% | 0.00% | – |
| Q1 2021 | $12,000 | -80.6% | 590 | -76.8% | 0.00% | – |
| Q4 2020 | $62,000 | -22.5% | 2,540 | -10.6% | 0.00% | -100.0% |
| Q3 2020 | $80,000 | +1500.0% | 2,840 | +186.9% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 990 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -94.0% | 990 | -76.4% | 0.00% | -100.0% |
| Q3 2017 | $67,000 | +34.0% | 4,200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $50,000 | – | 4,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |